Skip to main content
    M

    Mereo BioPharma Group PLC ADR (MREO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.31
    -0.00 (-0.13%)

    Market Cap: $49.42M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    65%(13/20)
    Avg Surprise
    -93.61%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.01
    Range$-0.03 - $-0.01
    6 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.01-57.1%
    60d ago$-0.01-57.1%
    30d ago$-0.010.0%
    7d ago$-0.010.0%
    Current$-0.01
    Revenue Consensus
    $0
    Range$0 - $0
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.03
    Range$-0.11 - $-0.01
    6 analysts
    Revenue Consensus
    $-5226330
    Range$-5226330 - $-5226330
    5 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.03---
    Sep 26EST
    		-$-0.01---
    Jun 26
    Reported Aug 11
    		$-0.01$-0.01+0.00%Beat+0.0%
    Mar 26
    Reported May 12
    		$-0.01$-0.01+43.41%Beat+63.5%
    Dec 25
    Reported Mar 19
    		$-0.01$-0.01+0.00%Beat+0.0%
    Sep 25
    Reported Nov 10
    		$-0.01$0.01-175.19%Miss+50.0%
    Jun 25
    Reported Aug 12
    		$-0.01$-0.01+0.00%Beat+50.0%
    Mar 25
    Reported May 13
    		$-0.02$-0.01-100.00%Miss+68.7%
    Dec 24
    Reported Mar 26
    		$-0.01$-0.01+0.00%Beat+33.3%
    Sep 24
    Reported Nov 12
    		$-0.02$-0.01-100.00%Miss-
    Jun 24
    Reported Aug 13
    		$-0.02$-0.01-100.00%Miss+0.0%
    Mar 24
    Reported May 15
    		$-0.06$-0.01-539.00%Miss-
    Dec 23
    Reported Mar 27
    		$-0.01$-0.02+25.00%Beat+25.0%
    Sep 23
    Reported Nov 17
    		$0.00$0.00N/ABeat-100.0%
    Jun 23
    Reported Sep 7
    		$-0.02$-0.02+0.00%Beat+61.2%
    Mar 23
    Reported Jun 27
    		$0.00$0.00N/ABeat-100.0%
    Dec 22
    Reported Mar 28
    		$-0.02$-0.02+0.00%Beat+88.2%
    Sep 22
    Reported Nov 2
    		$0.06$-0.02+400.00%Beat+5900.0%
    Jun 22
    Reported Jun 30
    		$-0.05N/AN/ABeat-
    Mar 22
    Reported Apr 1
    		$0.00N/A+100.04%Beat+101.4%
    Dec 21
    Reported Mar 31
    		$-0.17$-0.03-466.67%Miss-301.9%
    Sep 21
    Reported Nov 8
    		$0.00N/A+100.04%Beat+100.4%
    Jun 21
    Reported Aug 11
    		$0.00N/A+100.00%Beat+100.0%
    Mar 21
    Reported Jun 2
    		$-0.14$-0.14+0.50%Beat+95.7%
    Dec 20
    Reported Mar 31
    		$0.08$0.00N/ABeat+102.6%
    Sep 20
    Reported Dec 31
    		$-0.24$0.00N/AMiss+59.3%
    Jun 20
    Reported Sep 29
    		$-0.23$0.00N/AMiss+58.7%
    Mar 20
    Reported Jun 15
    		$-3.28$-0.26-1160.38%Miss-369.1%
    Dec 19
    Reported Mar 31
    		$-3.29$0.00N/AMiss-359.0%
    Sep 19
    Reported Dec 31
    		$-0.59$0.00N/AMiss+12.5%
    Jun 19
    Reported Sep 17
    		$-0.54$0.00N/AMiss+20.5%
    Mar 19
    Reported Apr 29
    		$-0.70$0.00N/AMiss+11.8%
    Dec 18
    Reported Mar 31
    		$-0.72$0.00N/AMiss+14.9%
    Sep 18
    Reported Dec 31
    		$-0.67$0.00N/AMiss+12.4%
    Jun 18
    Reported Sep 30
    		$-0.69$0.00N/AMiss+9.8%
    Mar 18
    Reported Jun 30
    		$-0.79$0.00N/AMiss+28.1%
    Dec 17
    Reported Mar 30
    		$-0.84$0.00N/AMiss+20.6%
    Sep 17
    Reported Dec 31
    		$-0.77$0.00N/AMiss-
    Jun 17
    Reported Sep 30
    		$-0.76$0.00N/AMiss-
    Mar 17
    Reported Jun 30
    		$-1.10$0.00N/AMiss-
    Dec 16
    Reported Mar 30
    		$-1.06$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-8.29EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-67.80%ROIC-112.24%
    Financial Health
    Debt/Equity0.04xInterest Coverage-391.57x
    Current Ratio5.88xQuick Ratio5.88x
    Trading Statistics
    Beta0.14Avg Volume1.71M
    52-Week High$2.3752-Week Low$0.20

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.34
    SMA 20$0.35
    SMA 50$0.31
    SMA 200$0.34
    EMA 10$0.33
    EMA 20$0.33
    EMA 50$0.32
    EMA 200$0.55

    MACD

    Line: 0.01Signal: 0.01Hist: -0.01

    ADX

    ADX: 34.6+DI: 20.6-DI: 15.0

    Aroon & PSAR

    Aroon Up56.0
    Aroon DownN/A
    PSAR$0.38

    Bollinger Bands

    Upper Band$0.41
    Lower Band$0.28
    %B Position3712%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    44.9

    Momentum Oscillators

    Stoch %K12.3
    Stoch %D15.1
    Williams %R-90.7
    ROC (10d)-15.8%
    Momentum-0.06
    CCI (20d)-91.7
    MFI (14d)51.8

    Volatility Measures

    ATR (14d)$0.03(10.4%)
    StdDev (20d)0.03
    Hist Vol97.2%(High)

    Volume Flow

    VWAP$0.31
    OBV45.2M
    AD Line146.4M
    CMF (20d)0.036

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio0.3x(Low)
    VWMA (20d)$0.35

    Pivot Points

    R3$0.34
    R2$0.33
    R1$0.32
    Pivot Point$0.31
    S1$0.30
    S2$0.29
    S3$0.28

    Advanced Oscillators

    TSI5.27
    Ultimate Osc42.8
    KST218.73

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$500,000$0$1.06M$0$0$0$1.00M$533,429
    Cost of Revenue$0$304,488$591,144$1,000$132,000$271,036$271,459$284,892$257,288$274,842$-273,000$-235,000
    Gross Profit$0$-304,488$-591,144$-1,000$368,000$-271,036$-271,459$-284,892$-257,288$-274,842$1.27M$235,000
    Operating Expenses$7.03M$8.45M$7.79M$10.01M$10.87M$11.20M$14.86M$9.37M$12.81M$9.90M$8.40M$9.30M
    R&D$1.81M$4.74M$4.19M$3.82M$5.37M$3.93M$8.74M$3.17M$4.95M$3.99M$4.80M$3.59M
    SG&A$5.22M$4.02M$4.20M$6.04M$5.49M$7.27M$6.45M$6.20M$7.87M$5.91M$3.60M$5.71M
    Operating Income$-7,030,000$-8,751,307$-8,377,878$-10,015,000$-10,499,000$-11,202,000$-15,133,368$-9,373,000$-12,814,000$-9,900,000$-7,128,000$-9,067,000
    Interest Income$278,000$327,000$421,000$504,000$589,000$659,000$881,000$983,000$559,000$617,000$763,000$689,000
    Interest Expense$16,000$20,000$22,966$27,831$24,000$180,000$371,522$353,000$331,000$310,000$353,000$700,000
    Income Before Tax$-7,005,000$-6,802,579$-7,812,696$-7,024,000$-14,616,000$-12,887,000$-7,551,327$-15,001,000$-12,255,000$-8,951,000$-9,641,000$-6,531,000
    Income Tax Expense$0$-94,840$-472,316$0$0$0$-570,659$-15,001,000$-369,413$-476,727$-532,000$235,580
    Net Income$-7,005,000$-6,707,738$-7,340,379$-7,024,000$-14,616,000$-12,887,000$-6,980,668$-15,001,000$-12,255,000$-8,951,000$-9,109,000$-6,531,000
    EBITDA$-6,690,000$-8,446,307$-7,785,878$-9,815,000$-14,294,000$-12,437,000$-14,859,368$-14,366,000$257,000$-8,366,000$-9,007,000$-5,549,000
    EBIT$-6,989,000$-8,751,307$-8,377,878$-9,869,000$-14,592,000$-12,707,000$-15,133,368$-14,648,000$0$-8,641,000$-9,288,000$-5,831,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MREO

    News

    Other investing cash flow items (total) of Mereo BioPharma Group plc Sponsored ADR – SWB:MAH0

    This article provides financial data specifically on "Other investing cash flow items (total)" for Mereo BioPharma Group plc Sponsored ADR (SWB:MAH0). It indicates that for the displayed period, there is a value...

    TradingView•10/14/26•Neutral

    Mereo BioPharma Group PLC ADR Research & Ratings | MAH0

    This article provides research and ratings for Mereo BioPharma Group PLC ADR (MAH0), listed on the German Frankfurt market. It includes analyst ratings with an average price target of €2.00 and a "Sell" score...

    Barron's•9/28/26•Neutral

    MAH0 | Mereo BioPharma Group PLC ADR Stock Overview (Germany: Frankfurt)

    This article provides an overview of Mereo BioPharma Group PLC ADR (MAH0) traded in Frankfurt, Germany. It includes key financial data such as current trading price, year-to-date and 12-month changes, volume...

    Barron's•9/28/26•Somewhat-Bearish

    Mereo BioPharma Group PLC (MREO) Stock Price Target & Forecast

    This article provides an analysis of Mereo BioPharma Group PLC (MREO) stock, including analyst ratings, price targets, and financial forecasts. Based on 8 analysts, the average target price for MREO is $1.75...

    TradingKey•9/24/26•Bullish

    Cantor Fitzgerald reiterates Mereo BioPharma stock Overweight rating at $3 By Investing.com

    Cantor Fitzgerald has reiterated its Overweight rating for Mereo BioPharma Group (NASDAQ:MREO) with an unchanged price target of $3.00, despite the stock currently trading at $0.29. The firm updated its financial model...

    Investing.com South Africa•9/18/26•Somewhat-Bullish

    MREO Valuation and Fair Value

    P/E
    -8.3x
    P/B
    1.7x
    See GNG's fair value

    MREO Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROIC
    -112.2%
    ROE
    -67.8%

    MREO Competitors

    CompanyTicker
    Tela Bio IncTELA
    Envoy Medical Inc.COCH
    iBio, Inc. Common StockIBIO
    Klotho Neurosciences, Inc.KLTO
    Myomo IncMYO
    Elicio Therapeutics Inc.ELTX
    Alterity Therapeutics LtdATHE
    Precision Optics Corporation, Inc. Common stockPOCI

    Sector: Healthcare

    MREO Analyst Ratings

    Consensus
    Hold
    Analysts
    8
    Strong Buy
    1
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    1

    MREO Bull Case vs Bear Case

    Bull case

    • 62.5% of MREO's analyst ratings are Buy or Strong Buy.

    Bear case

    • MREO beat EPS estimates in 12.5% of its last 8 reported quarters.

    MREO Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -41.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.01
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About MREO

    Does MREO pay dividends?

    Mereo BioPharma Group PLC ADR (MREO) does not currently pay a regular dividend.

    What is MREO's market cap?

    Mereo BioPharma Group PLC ADR (MREO) has a market capitalization of $49.42M with a current stock price of $0.31.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In